Molecular Underpinnings of Schizophrenia Spectrum Disorders
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 174
Special Issue Editors
Interests: psychiatric research
Interests: schizophrenia, psychoses; neuroimaging; omic science
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Schizophrenia spectrum disorders have a high lifetime prevalence (0.5–1%) and remain among the top 15 causes of years lived with disability worldwide. They strongly affect the functioning and quality of life for patients and their loved ones. The difficulties resulting from these disorders also generate economic problems in the form of considerable direct and mainly indirect costs. The molecular alterations underlying schizophrenia and related disorders are only marginally known. Therefore, studying the molecular biology of this group of psychiatric conditions is of extreme scientific interest. In particular, the disorder encompasses various symptoms and lies at the interface between neurodevelopment and neuroprogression processes affecting the central nervous system (CNS). Omics sciences and artificial intelligence are revolutionizing how we approach the biology of complex biological systems such as the CNS and its disorders. The application of these methods to patients with schizophrenia spectrum disorders might provide exciting insights into their pathophysiology, the relationship between specific molecular findings and various symptom domains, and open new avenues for identifying possible new molecular targets.
We therefore invite researchers working in this field to submit original research articles or reviews describing and discussing the most recent advancements and developments regarding the molecular underpinnings of schizophrenia spectrum disorders.
Potential topics include, but are not limited to:
- Genetic or genomic studies on schizophrenia spectrum disorders;
- Epigenetic or transcriptomic studies on schizophrenia spectrum disorders;
- Proteomic and metabolomic studies on schizophrenia spectrum disorders;
- Molecular studies on schizophrenia applying deep learning techniques;
- Studies that correlate the symptoms or cognitive characteristics of schizophrenia spectrum disorders with molecular aspects.
Prof. Dr. Paola Rocca
Dr. Claudio Brasso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- schizophrenia spectrum disorders
- central nervous system (CNS)
- psychotic disorders
